These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Ikebe S; Harada T; Hashimoto T; Kanazawa I; Kuno S; Mizuno Y; Mizuta E; Murata M; Nagatsu T; Nakamura S; Takubo H; Yanagisawa N; Narabayashi H Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S47-9. PubMed ID: 12735915 [TBL] [Abstract][Full Text] [Related]
29. [Neuroleptic malignant-like syndrome following abrupt withdrawal of baclofen]. Adeva-Bartolomé MT; Alonso-Navarro H; Martín-Prieto M; Jiménez-Jiménez FJ Med Clin (Barc); 2006 Jun; 127(2):79. PubMed ID: 16801014 [No Abstract] [Full Text] [Related]
30. [A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome]. Kumagai R; Harada T; Kurokawa K; Okazaki M; Egi N; Shimote K; Nakamura S No To Shinkei; 1998 Aug; 50(8):745-9. PubMed ID: 9757468 [TBL] [Abstract][Full Text] [Related]
31. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report. Fiore S; Persichino L; Anticoli S; De Pandis MF Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468 [TBL] [Abstract][Full Text] [Related]
32. Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease--a case report. Wu YF; Kan YS; Yang CH Gen Hosp Psychiatry; 2011; 33(3):301.e7-8. PubMed ID: 21601731 [TBL] [Abstract][Full Text] [Related]
34. A case of malignant syndrome associated with a parkinsonism patient. Sanga M; Nomura S Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221 [TBL] [Abstract][Full Text] [Related]
35. Neuroleptic malignant syndrome and amantadine withdrawal. Lazarus A Am J Psychiatry; 1985 Jan; 142(1):142. PubMed ID: 3966578 [No Abstract] [Full Text] [Related]
36. [Toxic and adverse neurological effects of anti-parkinsonian drugs]. Sunohara N Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):527-31. PubMed ID: 10434715 [No Abstract] [Full Text] [Related]
37. Serum creatine kinase is elevated in patients with Parkinson's disease: a case controlled study. Takubo H; Shimoda-Matsubayashi S; Mizuno Y Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S43-6. PubMed ID: 12735914 [TBL] [Abstract][Full Text] [Related]